Ursodeoxycholic Acid Attenuates Lipopolysaccharide-Induced Myocardial Injury by Inhibiting Oxidative Stress, Inflammation, and Apoptosis: The Interplay of Sirt1/Nrf2 and Akt/NF-κB Signaling Pathways
International Journal of Molecular Sciences · 20.03.2026 · 27 (6) · 2843
DOI: 10.3390/ijms27062843 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.03.2026. Verfasst von Ranko Škrbić und 17 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Biomedical Research, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, The Republic of Srpska, Bosnia and Herzegovina. Hauptthemen laut MEDLINE: Apoptosis, Cardiomyopathies, Myocardium, NF-E2-Related Factor 2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Oxidative stress is a critical pathophysiological factor in sepsis. Ursodeoxycholic acid (UDCA), a bile acid with anti-inflammatory, antioxidant, and anti-apoptotic properties, may protect against lipopolysaccharide (LPS)-induced myocardial injury. In an experimental study, 32 male Wistar rats were randomly assigned to four groups: control, LPS, UDCA, and UDCA + LPS. UDCA was administered orally for 10 days prior to LPS-induced endotoxemia. Serum levels of high-sensitive troponin I (hsTnI), homocysteine, and oxidative stress markers were measured, and immunohistochemistry and immunofluorescence were used to assess inflammation (nuclear factor kappa B, NF-κB), apoptosis (caspase 3), and signaling pathways related to protein kinase B (Akt)/NF-κB and silent information regulator 1 (SIRT1)/nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1). UDCA pretreatment significantly reduced myocardial pathological changes, serum hsTnI, homocysteine, and total oxidative stress compared with LPS alone. It enhanced catalase (CAT) activity and glutathione (GSH) levels while lowering thiobarbituric acid reactive substances (TBARS) and nitrite concentrations in cardiac tissue. UDCA modulated cellular signaling by decreasing Akt phosphorylation and activating the SIRT1/Nrf2/HO-1 pathway. These results indicate that UDCA protects the heart from LPS-induced damage by reducing oxidative stress, inflammation, and apoptosis. UDCA modulates cellular signaling by decreasing pro-inflammatory pathways and activating anti-inflammatory pathways associated with SIRT1/Nrf2/HO-1 signaling, emphasizing its key role in myocardial protection during sepsis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Biomedical Research, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, The Republic of Srpska, Bosnia and Herzegovina.
- Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, The Republic of Srpska, Bosnia and Herzegovina.
- Department of Pathophysiology, First Moscow State Medical University I.M. Sechenov, 119435 Moscow, Russia.
- Academy of Science and Arts of the Republic of Srpska, 78000 Banja Luka, The Republic of Srpska, Bosnia and Herzegovina.
- Department of Pathophysiology, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, The Republic of Srpska, Bosnia and Herzegovina.
- Department of Hygiene, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, The Republic of Srpska, Bosnia and Herzegovina.
ORCID-Profile: Ranko Škrbić, Tatjana Milivojac, Milkica Grabež, Ljiljana Amidžić, Zorislava Bajic, Tanja Sobot, Nebojša Mandić-Kovačević, Snežana Uletilović, Milica Gajic Bojic, Sanja Jovičić, Nataša Vojinović, Miloš P Stojiljković, Dragan M Djuric, Hani Al-Salami, Momir Mikov
Zitieren
APA
Škrbić, R., Milivojac, T., Grabež, M., Amidžić, L., Bajic, Z., Sobot, T., Mandić-Kovačević, N., Uletilović, S., Đukanović, Đ., Gajic Bojic, M., Jovičić, S., Barudžija, M., Vojinović, N., Stojiljković, M. P., Djuric, D. M., Al-Salami, H., Bolevich, S., & Mikov, M. (2026). Ursodeoxycholic Acid Attenuates Lipopolysaccharide-Induced Myocardial Injury by Inhibiting Oxidative Stress, Inflammation, and Apoptosis: The Interplay of Sirt1/Nrf2 and Akt/NF-κB Signaling Pathways. International Journal of Molecular Sciences, 27(6), 2843. https://doi.org/10.3390/ijms27062843
Vancouver
Škrbić R, Milivojac T, Grabež M, Amidžić L, Bajic Z, Sobot T, et al. Ursodeoxycholic Acid Attenuates Lipopolysaccharide-Induced Myocardial Injury by Inhibiting Oxidative Stress, Inflammation, and Apoptosis: The Interplay of Sirt1/Nrf2 and Akt/NF-κB Signaling Pathways. International Journal of Molecular Sciences. 2026;27(6):2843. doi:10.3390/ijms27062843
BibTeX
@article{krbi2026,
author = {Škrbić, Ranko and Milivojac, Tatjana and Grabež, Milkica and Amidžić, Ljiljana and Bajic, Zorislava and Sobot, Tanja and Mandić-Kovačević, Nebojša and Uletilović, Snežana and Đukanović, Đorđe and Gajic Bojic, Milica and Jovičić, Sanja and Barudžija, Maja and Vojinović, Nataša and Stojiljković, Miloš P and Djuric, Dragan M and Al-Salami, Hani and Bolevich, Sergey and Mikov, Momir},
title = {Ursodeoxycholic Acid Attenuates Lipopolysaccharide-Induced Myocardial Injury by Inhibiting Oxidative Stress, Inflammation, and Apoptosis: The Interplay of Sirt1/Nrf2 and Akt/NF-κB Signaling Pathways},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {6},
pages = {2843},
doi = {10.3390/ijms27062843}
}
EUVIMED